3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

R. Gagliardini, A. Bandera, M. Zaccarelli, G. Sterrantino, A. Latini, A. D’Avino, G. Lapadula, A. Antinori, R. Cauda, A. De Luca, A. Gori, S.D. Giambenedetto, M. Fabbiani

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalAntiviral Therapy
Issue number2
Publication statusPublished - 2018

Cite this